Document:

Exhibit 10.5

 

CLEMENTIA
PHARMACEUTICALS INC.

Second AMENDED AND RESTATED STOCK OPTION PLAN

 

JUNE 22, 2015

 

Article
1

PURPOSE

 

	1.1	Purpose

 

The purpose of this Second Amended and
Restated Stock Option Plan is to develop the interest and incentive of eligible employees, Directors, officers and Consultants
of Clementia Pharmaceuticals Inc. (the “Corporation”) or of its Affiliates, in the Corporation’s and its
Affiliates’ growth and development by giving eligible employees, Directors, officers and Consultants an opportunity to purchase
a total aggregate maximum amount of common shares of the capital of the Corporation (the “Common Shares”) equal
to 315,837 Common Shares (as such number may be adjusted pursuant to Article 5), providing incentives thereby advancing the interests
of the Corporation and its Affiliates, enhancing the value of the Common Shares for the benefit of all the shareholders and increasing
the ability of the Corporation and its Affiliates to attract, motivate and retain skilled and motivated individuals in the service
of the Corporation and its Affiliates.

 

Article
2

INTERPRETATION

 

	2.1	Definitions

 

When used herein, unless the context or
NI 45-106 otherwise requires, the following terms have the following meanings, respectively:

 

		(a)	“Affiliate” has the meaning attributed to that term in NI 45-106;

 

		(b)	“As-Converted Basis” means the number of Shares that would be issued and outstanding
should the Class A Preferred Shares and Class B Preferred Shares be converted into Common Shares of the Corporation in accordance
with their terms;

 

		(c)	“Board” means the board of directors of the Corporation;

 

		(d)	“Business Day” means a day that is not a Saturday, Sunday or a statutory or
legal holiday in the Province of Québec;

 

		(e)	“Cause” means with respect to any Participant who is an employee or Consultant
of the Corporation or of any of its Affiliates: (i) any theft, fraud, dishonesty, or serious misconduct by such Participant involving
the property, business or affairs of the Corporation or any of its Affiliates or the carrying out of the Participant’s duties
as an employee or Consultant of the Corporation or of any of its Affiliates, (ii) any material breach or non-observance by such
Participant of any term of the employment or consulting agreement with such Participant, including gross negligence and consistent

    	 

    	

    

failure or refusal
to perform his or her duties or responsibilities, after having been notified of such by the Corporation or its relevant Affiliate
and failed to remedy the situation within a reasonable delay, (iii) any conviction of such Participant to an indictable offense
by a court of competent jurisdiction, or (iv) any other action recognized as “just and sufficient cause” or “serious
reason” under applicable laws;

 

		(f)	“Class A Preferred Shares” means the Class A convertible preferred shares in
the capital of the Corporation;

 

		(g)	“Class B Preferred Shares” means the Class B convertible preferred shares in
the capital of the Corporation;

 

		(h)	“Committee” has the meaning attributed to that term in Section 3.2 hereof;

 

		(i)	“Common Shares” means the common shares in the capital of the Corporation;

 

		(j)	“Consultants” has the meaning attributed to that term in NI 45-106;

 

		(k)	“Convertible Securities” means any right, unit, option, warrant or any other
security, including, without limitation, any loan, note or any other instrument or agreement evidencing indebtedness of the Corporation,
which may be converted or exchanged into shares in the capital of the Corporation or which carries a right to acquire shares in
the capital of the Corporation;

 

		(l)	“Date of Grant” means, for any Option, the date specified by the Board at the
time it grants the Option or, if no such date is specified, the date upon which the Option was granted;

 

		(m)	“Director” means a member of the Board;

 

		(n)	“Disability” means the mental or physical state of a Participant such that:

 

		i)	the Board, other than the Participant, unanimously determine that the Participant has been unable,
due to illness, disease, mental or physical disability, as confirmed by an independent medical evaluation conducted by a physician
selected by the Board, to fulfill his obligations as an employee, Directors, officer or Consultant of the Corporation either for
any consecutive six-month period or for any non-consecutives periods that, in the aggregate, total 12 months in any consecutive
24-month period; or

 

		ii)	a court of competent jurisdiction has declared the Participant to be mentally incompetent or incapable
of managing his affairs;

 

		(o)	“Exercise Notice” means a notice in writing, in the form set out in Schedule
“B” hereto, signed by Participant and stating the Participant’s intention to exercise a particular Option;

    	 

    	

    

		(p)	“Exercise Price” means the price at which a Common Share may be purchased pursuant
to the exercise of an Option;

 

		(q)	“Exercise Period” means the period of time during which an Option granted under
this Plan may be exercised, provided however that the Exercise Period may not exceed ten (10) years from the relevant Date of Grant;

 

		(r)	“Fully Diluted Basis” means the number of Common Shares outstanding at any time
on an As-Converted Basis, including any stock dividends which have been declared but not issued and assuming all Convertible Securities
have been converted or exchanged into Shares and all outstanding options, including those granted pursuant to this Plan, have been
exercised;

 

		(s)	“Intellectual Property Rights” means any and all of the following in any and
all legal jurisdictions around the world: (i) patents, patent applications, patent disclosures and all related continuations, continuations-in-part,
divisionals, reissues, re-examinations and renewals, (ii) trademarks, service marks, trade dress, logos, trade names, service names,
domain names and corporate names, and registrations and applications for registration thereof, (iii) copyrights, and registrations
and applications for registration thereof, (iv) mask works, and registrations and applications for registration thereof, (v) trade
secrets and confidential business information, including without limitation, know-how, manufacturing and product processes and techniques,
biomaterials, research and development information, financial, marketing and business data, pricing and cost information, technical
data, business and marketing plans, and customer and supplier lists and information, and (vi) other proprietary rights relating
to any of the foregoing (including without limitation associated goodwill and remedies against infringements thereof and rights
of protection of an interest therein under the laws of all jurisdictions);

 

		(t)	“IPO” means an initial public offering of the Common Shares resulting in the
Common Shares being listed on a major stock exchange in the United States, Canada, Europe or Asia;

 

		(u)	“Liquidity Event” means a merger or consolidation or other transaction in which
greater than or equal to 50% of the voting power of shareholders of the Corporation is transferred to a third party or a sale,
lease, license, transfer or other disposition of all or substantially all of the assets or Intellectual Property Rights of the
Corporation (except to an Affiliate);

 

		(v)	“NI 45-106” means National Instrument 45-106 – Prospectus and Registration
Exemptions, as the same may be amended and/or replaced or supplanted from time to time;

 

		(w)	“Option” means a non-assignable, non-transferable right to purchase Common Shares
under this Plan;

 

		(x)	“Participant” means a current full-time or part-time employee, a Consultant,
a Director or an officer of the Corporation or of any of its Affiliates;

 

		(y)	“person” includes:

    	 

    	

    

		i)	an individual;

 

		ii)	a corporation;

 

		iii)	a partnership, trust, fund, syndicate, an association, organization, or other organized group of
persons, whether incorporated or not; and

 

		iv)	an individual or other person in that person’s capacity as trustee, executor, administrator
or personal or other legal representative;

 

		(z)	“Plan” means this Second Amended and Restated Stock Option Plan;

 

		(aa)	“Shareholders’ Agreement” means the second amended and restated unanimous
shareholders’ agreement of the Corporation dated as of June 22, 2015, as may be amended, restated or replaced from time to
time;

 

		(bb)	“Shares” means all shares of the Corporation issued and outstanding at any particular
time and includes the Common Shares, the Class A Preferred Shares, the Class B Preferred Shares, and any shares or securities into
which Shares may be converted or changed or that result from a consolidation, subdivision, reclassification or redesignation of
Shares, any shares or securities that are received as a stock dividend or distribution payable in shares or securities of the Corporation,
any shares received on the exercise of any option; warrant or other similar right and any shares or securities that may be received
by the parties hereto or bound hereby as a result of an amalgamation, merger, arrangement or other reorganization of or including
the Corporation;

 

		(cc)	“Stock Option Agreement” means a signed, written agreement between Participant
and the Corporation, in the form attached as Schedule “A” hereto, subject to any amendments or additions thereto as
may, in the discretion of the Board, be necessary or advisable, evidencing the terms and conditions on which an Option has been
granted under this Plan;

 

		(dd)	“Termination Date” means:

 

		i)	in the case of a Participant whose employment, directorship or term of office with the Corporation
or any of its Affiliates is terminated for any reason other than death, Disability or resignation, including a termination with
or without Cause, the earlier of: (a) the date that is the last day of the minimum statutory notice period applicable to the Participant
pursuant to applicable employment standards legislation in the Province of Québec or other foreign applicable laws, if any,
and (b) the date that is designated by the Corporation or any of its Affiliates, as applicable, as the last day of the Participant’s
employment or term of office with the Corporation or any of its Affiliates, as applicable, and “Termination Date”
specifically does not mean the date on which any period of reasonable notice that the Corporation or any of its Affiliates, as
applicable, may be required at law to provide to the Participant (other than the minimum statutory notice period as applicable),
would expire;

    	 

    	

    

		ii)	in the case of a Participant whose employment, services, directorship or term of office with the
Corporation or any of its Affiliates is terminated by reason of the death or Disability of the Participant, the date of death or
Disability of such Participant;

 

		iii)	in the case of a Participant whose employment, services, directorship or term of office with the
Corporation or any of its Affiliates is terminated by reason of the resignation of the Participant, the effective date of such
resignation;

 

		iv)	in the case of a Participant who is a Consultant and whose consulting agreement or arrangement
with the Corporation or any of its Affiliates terminates in the circumstances set out in subsection 4.8(d) hereof, the date that
is designated by the Corporation or its relevant Affiliate as the date on which the Participant’s consulting agreement or
arrangement is terminated, and “Termination Date” specifically does not mean the date on which any period of
notice of termination that the Corporation or its relevant Affiliate may be required to provide to the Participant under the terms
of the consulting agreement or arrangement, would expire; and

 

		(ee)	“Voting Trust Agreement” means any voting trust agreement of the Corporation
generally applicable to its shareholders who are otherwise Participants in force or to be put in place at any given time and includes
any power of attorney required to be provided pursuant thereto.

 

	2.2	Interpretation

 

		(a)	Whenever the Board or, where applicable, the Committee, is to exercise discretion in the administration
of the terms and conditions of this Plan, the term “discretion” means the sole and absolute discretion of the Board
or the Committee, as the case may be.

 

		(b)	As used herein, the terms “Article”, “Section”, “sub-section”
and “paragraph” mean and refer to the specified Article, Section, sub-section and paragraph hereof, respectively.

 

		(c)	Words importing the singular include the plural and vice versa and words importing any gender include
any other gender.

 

		(d)	In this Plan, a person (first person) is considered to control another person (second person) if
the first person, directly or indirectly, has the power to direct the management and policies of the second person by virtue of:

 

		i)	ownership of or direction over voting securities in the second person;

 

		ii)	a written agreement or indenture;

 

		iii)	being the general partner or controlling the general partner of the second person; or

 

		iv)	being a trustee of the second person.

    	 

    	

    

		(e)	Unless otherwise specified, all references to money amounts are to Canadian currency.

 

Article
3

ADMINISTRATION

 

	3.1	Administration

 

Subject to Section 3.2 hereof and the provisions
of the Shareholders’ Agreement, this Plan will be administered by the Board and the Board has sole and complete authority,
in its discretion, to:

 

	(a)	determine the individuals (from among the Participants) to whom Options may be granted;

 

	(b)	grant Options in such amounts and, subject to the provisions of this Plan, on such terms and conditions
as it determines including:

 

		i)	the time or times at which Options may be granted;

 

		ii)	the Exercise Price of any Option;

 

		iii)	the time or times when an Option becomes exercisable and, subject to Section 4.3 hereof, the duration
of the Exercise Period of an Option;

 

		iv)	without limiting Section 4.10 hereof, whether restrictions or limitations are to be imposed on
Common Shares that may be purchased pursuant to the exercise of any Option and the nature of such restrictions or limitations,
if any; and

 

		v)	any acceleration of exercisability or waiver of termination regarding any Option, based on such
factors as the Board may determine;

 

	(c)	interpret this Plan and adopt, amend and rescind administrative guidelines and other rules and
regulations relating to this Plan; and

 

	(d)	make all other determinations and take all other actions necessary or advisable for the implementation
and administration of this Plan.

 

The Board’s determinations and actions
within its authority under this Plan are conclusive and binding on the Corporation and all other persons. The day-to-day administration
of the Plan may be delegated to such officers and employees of the Corporation as the Board may in its sole discretion determine.

 

	3.2	Delegation
                                                                                                                                              to
                                                                                                                                              Committee

 

To the extent permitted by applicable law,
the Board may, from time to time, delegate to a committee (the “Committee”) of the Board all or any of the powers
conferred on the Board under the Plan. In such event, the Committee will exercise the powers delegated to it by the Board in the
manner and on the terms authorized by the Board. Any decision made or action

    	 

    	

    

taken by the Committee arising out of or
in connection with the administration or interpretation of this Plan in this context is final and conclusive.

 

	3.3	Total
                                                                          Common Shares Subject to Options

 

	(a)	The aggregate number of Common Shares that may be issued pursuant to the exercise of Options shall
not exceed 315,837 Common Shares, subject to any adjustment pursuant to Article 5.

 

	(b)	Notwithstanding the foregoing, in the event that the Common Shares become listed and posted for
trading on a major stock exchange in the United States, Canada, Europe or Asia, unless otherwise approved by holders of a majority
of the voting shares, the aggregate number of Common Shares which may be reserved for issuance under the Plan shall not exceed
the maximum permitted by the rules and policies of such stock exchange.

 

	(c)	If an Option terminates for any reason prior to its exercise in full or is cancelled, the Common
Shares issuable pursuant to such Option shall be added back to the number of Common Shares reserved for issuance under the Plan
and such Common Shares will again become available for grant under this Plan.

 

	3.4	Eligibility

 

Subject to Section 4.8 hereof, all Participants
are eligible to participate in the Plan. Eligibility to participate does not confer upon any Participant any right to be granted
Options pursuant to the Plan. The extent to which any Participant is entitled to be granted Options pursuant to the Plan will be
determined in the sole and absolute discretion of the Board.

 

	3.5	Stock
                                                                          Option Agreements

 

All grants of Options under Section 4.1
hereof shall be evidenced by Stock Option Agreements. Such Stock Option Agreements will be subject to the applicable provisions
of this Plan and will contain such further provisions as are required by this Plan and any other further provisions that the Board
may direct. Any one proper officer of the Corporation is authorized and empowered to execute and deliver, for and on behalf of
the Corporation, Stock Option Agreements to the Participants.

 

	3.6	Non-transferability

 

Except pursuant to Section 4.8, Options
granted under this Plan may only be exercised during the lifetime of the Participant by such Participant personally. No assignment
or transfer of Options, whether voluntary, involuntary, by operation of law or otherwise, vests any interest or right in such Options
whatsoever in any assignee or transferee and immediately upon any assignment or transfer, or any attempt to make the same, such
Options will terminate and be of no further force or effect.

    	 

    	

    

Article
4

GRANT OF OPTIONS

 

	4.1	Grant
                                                                          of Options

 

The Board may, from time to time, subject
to the provisions of this Plan and such other terms and conditions as the Board may prescribe, grant Options to any Participant.

 

	4.2	Exercise
                                                                          Price

 

Subject to the rules of any stock exchange
upon which the Common Shares may become listed, the Exercise Price of Common Shares under any Option shall be as determined by
the Board.

 

	4.3	Term
                                                                          of Options

 

Subject to the terms of the Plan and unless
an earlier termination date is specified by the Board and/or Stock Option Agreement, each Option expires on the earlier of the
following: (i) on the tenth (10th) anniversary of its Date of Grant or (ii) the time immediately following the closing
of a Liquidity Event.

 

	4.4	Vesting
                                                                          Period

 

Unless otherwise specified by (i) the Board
at the time of granting an Option, (ii) a Stock Option Agreement, or (iii) this Plan, 25% of each Option granted will vest on the
first anniversary of the Date of Grant, and an additional 1/36th will vest at the end of each month thereafter, such
that the entire Option will be vested following the fourth anniversary of the Date of Grant.

 

	4.5	Exercise
                                                                          Period

 

	(a)	Only the Options which have vested pursuant to section 4.4 and which have not yet expired or terminated
may be exercised by the Participant. Each Option or portion thereof which has vested and become exercisable may be exercised at
any time (except if then expired or terminated), in whole or in part, for up to the total number of Common Shares with respect
to which it is then exercisable. The Board may accelerate the date upon which any installment of any Option becomes exercisable.

 

	(b)	Subject to the provisions of this Plan and any Stock Option Agreement, Options may be exercised
by means of a fully completed Exercise Notice delivered to the Corporation together with payment therefor.

 

	(c)	The Corporation shall give written notice of any proposed Liquidity Event to each Participant,
together with a description of the effect of such Liquidity Event on outstanding Options, not less than ten (10) Business Days
prior to the closing of the transaction resulting in the Liquidity Event.

    	 

    	

    

	4.6	Payment
                                                                          of Exercise Price

 

An Exercise Notice must be accompanied
by payment in full of the purchase price for the Common Shares to be purchased thereby. Such Exercise Price must be fully paid
in cash, or by certified cheque, bank draft or money order payable to the Corporation or by such other means as might be specified
from time to time by the Board. No Common Shares will be issued pursuant to the exercise of any Option until full payment therefor
has been received by the Corporation. Subject to Section 4.10 hereof, as soon as practicable after receipt of any Exercise Notice
and full payment, the Corporation will deliver to the Participant a certificate or certificates representing the acquired Common
Shares.

 

	4.7	Special
                                                                          Rights of the Board

 

	(a)	Notwithstanding anything else in this Plan or in any Stock Option Agreement, the Board shall have
the right to provide for the conversion or exchange of any outstanding Options into or for options, rights or other securities
in any entity participating in or resulting from a Liquidity Event.

 

	(b)	In the event that the Corporation or its shareholders receive and accept an offer in respect of
a transaction that will result in a Liquidity Event, the Board may, in its sole discretion, deal with the Options issued under
the Plan in the manner it deems fair and reasonable in light of the circumstances of the Liquidity Event. Without limiting the
generality of the foregoing, in connection with a Liquidity Event, the Board may, without any action or consent required on the
part of any Participant, (i) deem any or all Options (vested or unvested) under the Plan to have been exercised and the Common
Shares issuable on such exercise to have been tendered in the course of the Liquidity Event, (ii) apply a portion of the Participant’s
proceeds from the closing of the Liquidity Event to the exercise price payable by that Participant for the exercise of his or her
Options, (iii) exchange unvested Options, or any portion of them, for options to purchase shares in the capital of the acquiror
or any corporation which results from an amalgamation, merger or similar transaction involving the Corporation made in connection
with the Liquidity Event or (iv) take such other actions, and combinations of the foregoing actions, as it deems fair and reasonable
under the circumstances.

 

	(c)	Without limiting the generality of Section 4.7(b) hereof, the Board may, in its sole discretion,
accelerate the vesting of any or all outstanding Options to provide that, notwithstanding Section 4.4 hereof or any Stock Option
Agreement, such outstanding Options shall be fully vested and conditionally exercisable upon (or prior to) the completion of the
Liquidity Event and require that if any such accelerated Options are not exercised within ten (10) Business Days following the
giving of the notice contemplated in Section 4.5 hereof, such unexercised Options shall terminate and expire upon the completion
of the proposed Liquidity Event, subject to any determination of the Board made pursuant to this Section 4.7. If, for any reason,
the Liquidity Event does not occur within the contemplated time period, the acceleration of the vesting of the Options shall be
retracted and vesting shall instead revert to the manner provided in Section 4.4 hereof.

    	 

    	

    

	4.8	Termination	 

 

Subject to the provisions of any Stock
Option Agreement:

 

	(a)	If, at any time, a Participant ceases to be an employee of the Corporation or of any of its Affiliates
as a result of any of the following: (i) the Participant’s death, (ii) the Participant’s Disability, or (iii) the Participant’s
termination for any reason whatsoever other than for Cause, the Options granted to such Participant and vested as of the Termination
Date shall remain exercisable by such Participant (or the Participant’s legal representative) until the earlier of: (i) 90
days following the Termination Date, and (ii) the expiration of such vested Options in accordance with their terms. In addition,
as of the Termination Date, all unvested Options of such Participant shall expire and be of no further force or effect whatsoever
and such Participant shall no longer be eligible for a grant of Options.

 

	(b)	If, at any time, a Participant ceases to be an employee of the Corporation or of any of its Affiliates
as a result of the termination for Cause, then, as of the Termination Date, all vested and unvested Options granted to such Participant
shall expire and be of no further force or effect whatsoever and such Participant shall no longer be eligible for a grant of Options.

 

	(c)	Where, in the case of a Consultant, the Participant’s consulting agreement or arrangement
terminates by reason of: (i) the Participant’s death, (ii) the Participant’s Disability, or (iii) the Participant’s
termination by the Corporation or its relevant Affiliate for any reason whatsoever other than for breach of the consulting agreement
or arrangement (whether or not such termination is effected in compliance with any termination provisions contained in the Participant’s
consulting agreement or arrangement), or (iv) voluntary termination by the Participant, then any Options granted to such Participant
and vested as of the Termination Date, or as of the date of the death or Disability of the Participant, as the case may be, shall
remain exercisable by such Participant until the earlier of: (i) 30 days following the Termination Date, or the date of the death
or Disability of the Participant, as the case may be; and (ii) the expiration of such vested Options in accordance with their terms.
In addition, as of the Termination Date, all unvested Options of such Participant shall expire and be of no further force or effect
whatsoever and such Participant shall no longer be eligible for a grant of Options.

 

	(d)	Where, in the case of a Consultant, the Participant’s consulting agreement or arrangement
is terminated by the Corporation or its relevant Affiliate for breach of the consulting agreement or arrangement or for Cause (whether
or not such termination is effected in compliance with any termination provisions contained in the Participant’s consulting
agreement or arrangement), then all vested and unvested Options granted to such Participant shall expire and be of no further force
or effect whatsoever and such Participant shall no longer be eligible for a grant of Options.

 

	(e)	If, at any time, a Participant ceases to be a Director or officer of the Corporation or any of
its Affiliates (and is not and does not continue as a Consultant or full-time employee of the Corporation or of any of its Affiliates),
the Options granted to such Participant and

    	 

    	

    

vested as of
the Termination Date may be exercised by such Participant pursuant to the same terms and conditions as those mentioned in subsections
4.8(c) and 4.8(d) above as if such Director or officer was a Consultant.

 

	(f)	Notwithstanding any other provisions of this Section 4.8, the Board may extend the expiration date
of vested and unvested Options of a Participant who ceases to be an employee, Consultant, officer or Director of the Corporation
or of any of its Affiliates beyond the expiry dates set out above, provided that such extended dates are not later than the assigned
expiry date of any such Option.

 

	(g)	Unless the Board otherwise determines, Options are not effected by a change of employment or consulting
arrangements within or among the Corporation its relevant Affiliate for so long as the employee or the Consultant continues to
be an employee or a Consultant of the Corporation or of any of its Affiliates.

 

	4.9	Discretion
                                                                          to Permit Exercise	 

 

Notwithstanding the provisions of Section
4.8 hereof, the Board may, in its discretion, at any time prior to or following the events contemplated in such section, permit
the exercise of any or all Options held by a Participant in the manner and on the terms authorized by the Board, provided that
the Board shall not, in any case, authorize the exercise of an Option pursuant to this Section 4.9 beyond the initial expiration
of the Exercise Period of the particular Option under the terms of the grant of such Option.

 

	4.10	Ancillary
                                                                           Agreements

 

Each Participant shall, at the time of
exercising an Option, execute and deiiver to the Corporation (a) a counterpart and acknowledgement to the Shareholders’ Agreement
or any other shareholders’ agreement, in force at such date (if such Participant is not already a party thereto) and (b)
if requested by the Corporation, a Voting Trust Agreement (collectively, the “Ancillary Agreements”). Each Participant
acknowledges that the Ancillary Agreements restrict transfers of Common Shares and may provide that any original share certificates
of the Corporation shall be held by the Corporation or its legal counsel.

 

	4.11	Conditions
                                                                           of Exercise

 

Each Participant shall, when requested
by the Corporation, sign and deliver all such documents relating to the granting or exercise of Options which the Corporation or
the Board deems necessary or desirable.

 

Article
5

SHARE CAPITAL ADJUSTMENTS

 

	5.1	General

 

The existence of any Options shall not
affect in any way the right or power of the Corporation or its shareholders to make, authorize or determine any adjustment, recapitalization,
reorganization or any other change in the Corporation’s capital structure or its business, or any amalgamation,

    	 

    	

    

combination, merger or consolidation involving
the Corporation, to create or issue any bonds, debentures, Common Shares or other securities of the Corporation or to determine
the rights and conditions attaching thereto, to effect the dissolution or liquidation of the Corporation or any sale or transfer
of all or any part of its assets or business, or to effect any other corporate act or proceeding, whether of a similar character
or otherwise, whether or not any such action referred to in this Section 5.1 would have an adverse effect on this Plan or any Option
granted hereunder.

 

	5.2	Reorganization
                                                                          of Corporation’s Capital

 

Should the Corporation effect a subdivision
or consolidation of Common Shares or any similar capital reorganization or a payment of a stock dividend (other than a stock dividend
that is in lieu of a cash dividend), or should any other change be made in the capitalization of the Corporation that, in the opinion
of the Board, would warrant an adjustment to the number of Common Shares referred to in Section 3.3(a), or the replacement of any
existing Options in order to adjust (a) the number of Common Shares that may be acquired on the exercise of any outstanding Options
and/or (b) the Exercise Price of any outstanding Options in order to preserve proportionately the rights and obligations of the
Participants, the Board shall authorize such steps to be taken as may be equitable and appropriate thereto.

 

	5.3	Other
                                                                          Events Affecting the Corporation

 

In the event of an amalgamation, combination,
merger or other reorganization involving the Corporation by exchange of Common Shares, by sale or lease of assets or otherwise,
that, in the opinion of the Board, warrants an adjustment to the number of Common Shares referred to in Section 3.3(a), or the
replacement of any existing Options in order to adjust (a) the number of Common Shares that may be acquired on the exercise of
any outstanding Options or (b) the Exercise Price of any outstanding Options in order to preserve proportionately the rights and
obligations of the Participants, the Board shall authorize such steps to be taken as may be equitable and appropriate thereto.

 

	5.4	Immediate
                                                                          Exercise of Options

 

Where the Board determines that the steps
provided in Sections 5.2 and 5.3 hereof would not preserve proportionately the rights and obligations of the Participants in the
circumstances or otherwise determines that it is appropriate, the Board may permit the immediate exercise of any outstanding Options
that are not otherwise exercisable.

 

	5.5	Issue
                                                                          by Corporation of Additional Shares

 

Except as expressly provided in this Article
5, neither the issue by the Corporation of shares of any class or securities convertible into or exchangeable for shares of any
class, nor any conversion or exchange of such shares or securities, shall affect, and no adjustment by reason thereof shall be
made with respect to (a) the number of Common Shares that may be acquired on the exercise of any outstanding Options or (b) the
Exercise Price of any outstanding Options.

    	 

    	

    

	5.6	Fractions

 

No fractional Common Shares will be issued
on the exercise of an Option. Accordingly, if, as a result of any adjustment under Sections 5.2 to 5.4 hereof inclusive, a Participant
would become entitled to a fractional Common Share, such Participant shall have the right to acquire only the adjusted number of
full Common Shares and no payment or other adjustment will be made with respect to the fractional Common Shares so disregarded.

 

	5.7	Conditions
                                                                          of Exercise

 

The Plan and each Option are subject to
the requirement that if at any time the Board determines that the listing, registration or qualification of the Common Shares subject
to such Option upon any stock exchange or under any provincial, state or federal law, or that the consent or approval of any governmental
body, stock exchange or of the holders of the Common Shares generally, is necessary or desirable, as a condition of, or in connection
with, the granting of such Option or the issue or purchase of Common Shares thereunder, no such Option may be granted or exercised
in whole or in part unless such listing, registration, qualification, consent or approval has been effected or obtained free of
any conditions not acceptable to the Board. The Participant shall, to the extent applicable, cooperate with the Corporation in
relation to such registration, qualification or other approval and shall have no claim or cause of action against the Corporation
or any of its officers or directors as a result of any failure by the Corporation to obtain or to take any steps to obtain any
such registration, qualification or approval.

 

Article
6

MISCELLANEOUS PROVISIONS

 

	6.1	Legal
                                                                          Requirement

 

The Corporation is not obligated to grant
any Options, issue any Common Shares or other securities, make any payments or take any other action if, in the opinion of the
Board, in its sole discretion, such action would constitute a violation by a Participant or the Corporation of any provision of
any applicable statutory or regulatory enactment of any government or government agency.

 

	6.2	Withholding
                                                                          Taxes

 

The exercise of each Option granted under
this Plan is subject to the condition that if at any time the Corporation determines, in its discretion, that the satisfaction
of withholding tax or other withholding liabilities is necessary or desirable in respect of such exercise, such exercise shall
not be effective unless such withholding has been effected to the satisfaction of the Corporation. In such circumstances, the Corporation
may require that a Participant pay to the Corporation, in addition to and in the same manner as the Exercise Price for the Common
Shares, such amount as the Corporation is obliged to remit to the relevant taxing authority in respect of the exercise of any such
Option. Any such additional payment is due no later than the date of exercise of the relevant Options.

    	 

    	

    

	6.3	Rights
                                                                          of Participant

 

No Participant shall have any claim or
right to be granted an Option (including, without limitation, an Option granted in substitution for any Option that has expired
pursuant to the terms of this Plan), and the granting of any Option is not to be construed as giving any Participant a right to
remain in the employ of the Corporation. No Participant shall have any rights as a shareholder of the Corporation in respect of
Common Shares issuable on the exercise of rights to acquire Common Shares under any Option until the allotment and issuance to
the Participant of certificates representing such Common Shares.

 

	6.4	Compliance
                                                                          with Stock Exchange

 

The Board may make changes to the terms
of any granted Options or the Plan to the extent necessary or desirable to comply with any rules, regulations or policies of any
stock exchange on which the Common Shares may be listed following an IPO, provided that the value of previously granted Options
and the rights of Participants are not materially adversely affected by any such changes.

 

	6.5	Termination;
                                                                          Amendment

 

	(a)	The Plan will terminate and, for greater certainty, all unexercised Options shall terminate and
expire on the earliest of: (i) the date upon which no further Common Shares remain available for issuance pursuant to Options which
may be granted under the Plan and no Options remain outstanding; or (ii) immediately following closing of a Liquidity Event, unless
renewed for such further period or otherwise determined by the Board in accordance with Article 4, and upon such terms and conditions
as the Board may determine.

 

	(b)	Subject to the provisions of the Shareholders’ Agreement, the Board may, without notice,
at any time or from time to time, amend, suspend or terminate this Plan or any provisions hereof in such respects as it, in its
sole discretion, determines appropriate. No such amendment, suspension or termination of this Plan, without the consent of any
Participant or the representatives of such Participant’s estate, as applicable, shall alter or impair any rights or obligations
arising from any Option previously granted to any Participant under this Plan.

 

	6.6	Authorization
                                                                          of Sub Plans

 

Subject to the provisions of the Shareholders’
Agreement, the Board may from time to time establish one or more sub-plans under the Plan for purposes of satisfying applicable
blue sky, securities or tax laws of various jurisdictions. The Board shall establish such sub-plans by adopting supplements to
this Plan containing (a) such limitations on the Board’s discretion under the Plan as the Board deems necessary or desirable
or (b) such additional terms and conditions not otherwise inconsistent with the Plan as the Board shall deem necessary or desirable.
All supplements adopted by the Board, subject to the provisions of the Shareholders’ Agreement, shall be deemed to be part
of the Plan, but each supplement shall apply only to Participants within the affected jurisdiction and the Corporation shall not
be required to provide copies of any supplement to Participants in any jurisdiction which is not the subject of such supplement.

    	 

    	

    

	6.7	Participation
                                                                          in the Plan

 

The participation of any Participant in
the Plan is entirely voluntary and not obligatory and shall not be interpreted as conferring upon such Participant any rights or
privileges other than those rights and privileges expressly provided in the Plan. In particular, participation in the Plan does
not constitute a condition of employment nor a commitment on the part of the Corporation to ensure the continued employment of
such Participant. The Plan does not provide any guarantee against any loss which may result from fluctuations in the market value
of the Common Shares. The Corporation does not assume responsibility for the income or other tax consequences for the Participants
and they are advised to consult with their own tax advisors.

 

	6.8	Effective
                                                                          Date

 

This Plan becomes effective on the date
hereof.

 

	6.9	Governing
                                                                          Law

 

The Plan, and determinations made and actions
taken in connection with the Plan, shall be governed by the laws of the Province of Québec and the federal laws of Canada
and construed in accordance therewith.

 

	6.10	Language

 

The Board confirms that it is its wish
that the Plan, as well as other documents relating thereto, be drawn up in English only. Le conseil d’administration confirme
sa volonté que ce Plan, de même que tous les documents s’y rattachant, soient rédigés en anglais
seulement.

 

[signature page follows]

    	 

    	

    

The undersigned executes
this Second Amended and Restated Employee Stock Option Plan as of the date first written above.

 

	 	CLEMENTIA PHARMACEUTICALS INC.
	 	 	 
	 	Per:	 
	 	Name: 	Dr. Clarissa Desjardins
	 	Title:	President

    	 

    	

    

SCHEDULE
“A”

 

STOCK OPTION
AGREEMENT

 

Clementia Pharmaceuticals Inc. (the “Corporation”)
hereby grants to the Participant named below (the “Participant”), an option (the “Option”)
to purchase, in accordance with and subject to the terms, conditions and restrictions of this Agreement, together with the provisions
of the Second Amended and Restated Stock Option Plan (the “Plan”) of the Corporation dated June 22, 2015, the
number of common shares in the capital of the Corporation (“Common Shares”) at the price per share set forth
below:

 

	 	Name of Participant: Date of Grant:	 	 
	 	Number of Common Shares:	 	 
	 	Exercise Price:	 	 
	 	Exercise Period: 	 	 
	 	Vesting Period:	 	 

 

		1.	The terms and conditions of the Plan are hereby incorporated by reference as terms and conditions
of this Stock Option Agreement and all capitalized terms used herein, unless expressly defined in a different manner, have the
meanings ascribed thereto in the Plan.

 

		2.	Subject to Sections 4.7, 4.8 and 5.4 of the Plan, unless otherwise provided herein, each Option
is exercisable in the portions set forth in Section 4.4 of the Plan.

 

		3.	In no event is the Option granted hereunder exercisable after the expiration of the relevant Exercise
Period.

 

		4.	Nothing in the Plan or in this Stock Option Agreement will affect the Corporation’s or its
relevant Affiliate’s right, to terminate the employment of, or term of office of, or consulting agreement or arrangement
with a Participant at any time for any reason whatsoever. Upon such termination, a Participant’s rights to exercise Options
will be subject to restrictions and time limits for the exercise of Options. Complete details of such restrictions are set out
in the Plan, and in particular in Section 4.8 of the Plan.

 

		5.	Each notice relating to the Option, including the exercise thereof, must be in writing. All notices
to the Corporation must be delivered personally or by prepaid registered mail and must be addressed to the President of the Corporation.
All notices to the Participant will be addressed to the principal address of the Participant on file with the Corporation. Either
the Corporation or the Participant may designate a different address by written notice to the other. Such notices are deemed to
be received, if delivered personally, on the date of delivery, and if sent by prepaid, registered mail, on the fifth Business Day
following the date of mailing.

 

		6.	When the issuance of Common Shares on the exercise of the Option may, in the opinion of the Corporation,
conflict or be inconsistent with any applicable law or regulation of any governmental agency having jurisdiction, the Corporation
reserves the right to refuse to issue such Common Shares for so long as such conflict or inconsistency remains outstanding.

    	 

    	

    

		7.	Except as specifically permitted by the Plan, the Option granted pursuant to this Stock Option
Agreement may only be exercised during the lifetime of the Participant by the Participant personally and no assignment or transfer
of the Option, whether voluntary, involuntary, by operation of law or otherwise, vests any interest or right in such Option whatsoever
in any assignee or transferee, and immediately upon any assignment or transfer or any attempt to make such assignment or transfer,
the Option granted hereunder terminates and is of no further force or effect. Complete details of this restriction are set out
in the Plan.

 

		8.	The Participant hereby agrees that:

 

		a)	any rule, regulation or determination, including the interpretation by the Board of the Plan, the
Option granted hereunder and the exercise thereof, is final and conclusive for all purposes and binding on all persons including
the Corporation and the Participant; and

 

		b)	the grant of the Option does not affect in any way the right of the Corporation or its relevant
Affiliate to terminate the employment of the Participant.

 

		9.	The Participant acknowledges and agrees that

 

		a)	as a condition of exercise of any Options, the Participant must agree to become a party to and
be bound by any shareholders’ agreement and voting trust agreement then in effect, or otherwise required, applicable to the
Participant who acquires Common Shares through the exercise of Options;

 

		b)	the current version of such shareholders’ agreement, among other things: (i) severely restricts
any transfer of Common Shares; (ii) provides the Corporation and certain shareholders the right to purchase Common Shares at a
price which may, in certain circumstances, be less than the exercise price paid by the Participant to acquire its Common Shares;
(iii) may force the sale of the Common Shares underlying Options, including in connection with certain Liquidity Events, and (iv)
may grant power of attorney for the voting rights attached to the Common Shares; and

 

		c)	the voting trust agreement may among other things: (i) provide that the Common Shares acquired
upon exercise of the Option may only be voted by a third party (and not the Participant); or (ii) grant power of attorney for the
voting rights attached to the Shares.

 

Accordingly, if at any time the Participant
wishes to exercise any Options, the Participant should request from the Corporation a copy of the shareholders’ agreement
and voting trust agreement then in effect, or otherwise required, and applicable to the Participant who acquires Common Shares
through the exercise of Options and carefully review it prior to completing any exercise of Options.

    	A2

    	

    

		10.	This Stock Option Agreement has been made in and is to be construed under and in accordance with
the laws of the Province of Québec and the laws of Canada applicable therein.

 

		11.	The Participant confirms that it is its wish that the Plan, as well as other documents relating
thereto (including this Stock Option Agreement), be drawn up in English only. Le participant confirme sa volonté que
ce Plan, de même que tous les documents s’y rattachant (incluant cette entente d’options), soient rédigés
en anglais seulement.

 

	 	CLEMENTIA PHARMACEUTICALS INC.
	 	 	 	 
	 	By:	 	 
	 	 	Name:	 
	 	 	Title:	 

 

I have read the foregoing Stock Option
Agreement and hereby accept the Option to purchase Common Shares in accordance with and subject to the terms and conditions of
such Stock Option Agreement and the Plan. I understand that I may review the complete text of the Plan by contacting the President
of the Corporation. I agree to be bound by the terms and conditions of the Plan governing the award.

 

	Date Accepted	 	Participant’s Signature	 
	 	 	 	 
	 	 	 	 
	 	 	Participant’s Name

(Please Print)	 

    	A3

    	

    

SCHEDULE
“B”

 

STOCK OPTION
PLAN EXERCISE NOTICE FORM - OPTIONS

 

I,
___________________________________________________ (print name), hereby exercise the option to purchase
___________________________________ Common Shares of Clementia Pharmaceuticals Inc. (the “Corporation”) at
a purchase price of $ _________________ per Common Share. This Exercise Notice is delivered in respect of the option to
purchase ________________________ Common Shares of the Corporation that was granted to me on ____________________ pursuant to
the Stock Option Agreement entered into between the Corporation and me. In connection with the foregoing, I enclose cash, a
certified cheque, bank draft or money order payable to the Corporation in the amount of $ __________________ as
             full payment for the Common Shares to be
received upon exercise of the Option and all applicable withholding taxes.

 

	Date	 	Participant’s Signaturekcexhibit1001

 

 

 

 

 

 

 

 

 

Exhibit A – Summary of Benefit Programs 2017 – Vectrus IMPORTANT: This document represents a summary of how your participation in the Vectrus benefit programs will be impacted with your separation. Full details on benefit continuation and conversion can be found in each benefit plans Summary Plan Description found at www.cbizesc.com/Vectrus  Page | 1    Benefit Program Will I Remain Covered During Severance?  What Do I Pay? When Does Coverage End?  More Info/My Action Medical Yes, as long as you elected coverage for 2017.     You pay the same payroll contributions as if you were an active employee with Vectrus through your Severance Period. Deductions come directly out of your Severance pay. Last day of the month in which your final Severance pay is paid.  COBRA information will be sent to your home address approximately 7  to 10 business days after the last day of the month in which your final Severance pay is paid.   **See Notes on COBRA coverage below**   Dental Yes, as long as you elected coverage for 2017.     You pay the same payroll contributions as if you were an active employee with Vectrus through your Severance Period. Deductions come directly out of your Severance pay. Last day of the month in which your final Severance pay is paid.  COBRA information will be sent to your home address approximately 7  to 10 business days after the last day of the month in which your final Severance pay is paid.   **See Notes on COBRA coverage below**   Vision Yes, as long as you elected coverage for 2017.     You pay the same payroll contributions as if you were an active employee with Vectrus through your Severance Period. Deductions come directly out of your Severance pay. Last day of the month in which your final Severance pay is paid.  COBRA information will be sent to your home address approximately 7  to 10 business days after the last day of the month in which your final Severance pay is paid.   **See Notes on COBRA coverage below**   

 

Exhibit A – Summary of Benefit Programs 2017 – Vectrus IMPORTANT: This document represents a summary of how your participation in the Vectrus benefit programs will be impacted with your separation. Full details on benefit continuation and conversion can be found in each benefit plans Summary Plan Description found at www.cbizesc.com/Vectrus  Page | 2   Benefit Program Will I Remain Covered During Severance?  What Do I Pay? When Does Coverage End?  More Info/My Action Employer Provided Basic Life  Yes This benefit is provided by Vectrus at no charge to the employee.   Note: the Age reduction schedule would still apply. Last day of the month in which your final Severance pay is paid.   You may elect to convert this coverage to a personal policy.   Contact Tracy Hanavan at 719-637-5828 to receive the conversion forms.    You must submit the conversion forms to Cigna Group Insurance directly within 31 days of the coverage ending.   Cigna Group Insurance: 1- 800-732-1603 for more information.    Employer Provided Basic Accidental, Death and Dismemberment (AD&D) No      N/A        Coverage ends on the last day of the month of your last day of work.    You may elect to convert this coverage to a personal policy.   Contact Tracy Hanavan at 719-637-5828 to receive the conversion forms.    You must submit the conversion forms to Cigna Group Insurance directly within 31 days of the coverage ending.   Cigna Group Insurance: 1- 800-732-1603 for more information.    Voluntary  MetLife GUL (Domestic Employees and Grand Fathered International Employees) No       N/A            Coverage ends on your last day of work.   You may elect to convert this coverage to a personal direct pay policy.   You have 62 days before your policy will lapse due to non-payment of premium. Contact MetLife directly for conversation information.   Contact MetLife:  1-800-846-0124 or www.mybenefits.metlife.com  Voluntary  Life  with Cigna (International employees enrolled after June 2015)    No        N/A       Coverage ends on the last day of the month of your last day of work.   You may elect to convert this coverage to a personal policy.  Contact Tracy Hanavan at 719-637-5828 to receive the conversion forms.  You must submit the conversion forms to Cigna Group Insurance directly within 31 days of the coverage ending.  Cigna Group Insurance: 1- 800-732-1603 for more information.   

 

Exhibit A – Summary of Benefit Programs 2017 – Vectrus IMPORTANT: This document represents a summary of how your participation in the Vectrus benefit programs will be impacted with your separation. Full details on benefit continuation and conversion can be found in each benefit plans Summary Plan Description found at www.cbizesc.com/Vectrus  Page | 3   Benefit Program Will I Remain Covered During Severance?  What Do I Pay? When Does Coverage End?  More Info/My Action Voluntary  Accidental Death & Dismemberment (AD&D)   No        N/A      .  Coverage ends on the last day of the month of your last day of work.   You may elect to convert this coverage to a personal policy.  Contact Tracy Hanavan at 719-637-5828 to receive the conversion forms.  You must submit the conversion forms to Cigna Group Insurance directly within 31 days of the coverage ending.  Cigna Group Insurance: 1- 800-732-1603 for more information.   Short-Term Disability  No   N/A Coverage ends on your last day of work.  No conversion or portability offered. Long-Term Disability No       N/A      . Coverage ends on your last day of work.  You may elect to convert this coverage to a personal policy.  Contact Tracy Hanavan at 719-637-5828 to receive the conversion forms.  You must submit the conversion forms to Cigna Group Insurance directly within 31 days of the coverage ending.  Cigna Group Insurance: 1- 800-732-1603 for more information.   

 

Exhibit A – Summary of Benefit Programs 2017 – Vectrus IMPORTANT: This document represents a summary of how your participation in the Vectrus benefit programs will be impacted with your separation. Full details on benefit continuation and conversion can be found in each benefit plans Summary Plan Description found at www.cbizesc.com/Vectrus  Page | 4   Benefit Program Will I Remain Covered During Severance?  What Do I Pay? When Does Coverage End?  More Info/My Action Medical Flexible Spending Account  Yes, as long as you elected coverage for 2017.     You pay the same payroll contributions as though you remained an active employee. Deductions come directly out of your Severance Pay.  You may continue to submit claims for reimbursement using the same process you follow while you were at work. You may NOT submit claims for services incurred after your Severance Pay Period ends, the end of your COBRA continuation, or December 31, 2017, whichever occurs first.   Once you have completed your Severance Period, you will receive information on how to continue your coverage under COBRA.    **See Notes on COBRA coverage below**  For questions regarding your Flexible Spending account you may call CBIZ @ 1-800-815-3023 option 4   Dependent Care Flexible Spending    Account No Due to IRS rules, you may not contribute to the Dependent Care Spending Account during the Severance Period.  There is no COBRA continuation for this benefit.  You may continue to submit claims for reimbursement using the same process you follow while you were at work, provided the dependent care expense is incurred in order that you may work, even for another employer. You may submit claims until December 31, 2017.  Dependent Care FSA is not COBRA eligible. 

 

Exhibit A – Summary of Benefit Programs 2017 – Vectrus IMPORTANT: This document represents a summary of how your participation in the Vectrus benefit programs will be impacted with your separation. Full details on benefit continuation and conversion can be found in each benefit plans Summary Plan Description found at www.cbizesc.com/Vectrus  Page | 5   Benefit Program Will I Remain Covered During Severance?  What Do I Pay? When Does Coverage End??  More Info/My Action Transit and Parking  Flexible Spending    Account No Due to IRS rules, you may not contribute to the Transit and Parking Spending Accounts during the Severance Period.  There is no COBRA continuation for this benefit.  You may continue to submit claims for reimbursement using the same process you follow while you were at work, provided the Transit and Parking expense is incurred in order that you may work, even for another employer. You may submit claims until December 31, 2017.  Transit and Parking FSA’s are not COBRA eligible.  Healthcare Spending Account (HSA)  Yes, you can continue, elect or change your Health Savings Account contributions as long as you remain participating in the qualified High Deductible Health Plan (HDHP) in 2017.   You pay the same payroll contributions as though you remained  an active employee. Deductions come directly out of your Severance Pay.   Your contributions will be deposited in your HSA   and are always yours.  If you continue to elect HDHP plan through COBRA, you will remain eligible to contribute to your HSA but will have to make after-tax contributions directly to the HSA bank. For questions about your HSA, please contact CIGNA at: 1-800-244-6224 VOYA   Accident Insurance  Hospital Confinement  Critical Illness No       N/A      .  Coverage ends on the last day of the month of your last day of work.  You may elect to convert this coverage to a personal policy.  Contact Tracy Hanavan at 719-637-5828 to receive the conversion forms.  You must submit the conversion forms to VOYA/Compass directly within 31 days of the coverage ending.  VOYA/Compass: 1- 800-955-7736 for more information.   

 

Exhibit A – Summary of Benefit Programs 2017 – Vectrus IMPORTANT: This document represents a summary of how your participation in the Vectrus benefit programs will be impacted with your separation. Full details on benefit continuation and conversion can be found in each benefit plans Summary Plan Description found at www.cbizesc.com/Vectrus  Page | 6   Benefit Program Will I Remain Covered During Severance?  What Do I Pay? When Does Coverage End?  More Info/My Action  Vectrus 401(k)  Plan  No, you will no longer be eligible to participate in the Vectrus 401(k) plan.   N/A   Commencement of Severance Pay.    For questions regarding your Vectrus 401(k) Plan call: Prudential 1-877-778-2100 or go to  www.prudential.com/online/retirement    Vectrus 401(k) Loans  Yes, you are still eligible to continue loan repayments. Your normal loan payroll deduction will continue through your Severance Period. Loan deductions will stop once your Severance Period has ended or should you request a distribution from your account.  Once you have completed your Severance Period, you can contact Prudential to confirm if you qualify to continue manual loan payments.  For questions regarding your Vectrus 401(k) Plan call:  Prudential 1-877-778-2100 or go to  www.prudential.com/online/retirement  Vectrus 401(k) Distribution   Yes, since you are no longer eligible to participate in the plan, you will be eligible to receive a distribution from the plan. N/A Commencement of Severance Pay.  During your Severance Period, Prudential will continue to see you as an active employee.  If you are interested in receiving a distribution from your 401(k) account while on severance, you will need to contact Sandi Rasnake to assist with your distribution process.   sandi.rasnake@vectrus.com 719-637-6380   

 

Exhibit A – Summary of Benefit Programs 2017 – Vectrus IMPORTANT: This document represents a summary of how your participation in the Vectrus benefit programs will be impacted with your separation. Full details on benefit continuation and conversion can be found in each benefit plans Summary Plan Description found at www.cbizesc.com/Vectrus  Page | 7   Benefit Program Will I Remain Covered During Severance?  What Do I Pay? When Does Coverage End?  More Info/My Action **COBRA**  The 18 month continuation COBRA coverage period will begin when your Severance Period ends.   After your Severance Period has been completed, you will pay 102% of the full monthly premiums.  In most cases, COBRA can continue for up to 18 months after your employment ends.   Within a couple weeks after the end of the month that your severance ends, a COBRA package will automatically be sent to your home address.    For questions regarding your COBRA continuation rights you may call CBIZ @ 1-800-815-3023 option 6   

 

EXHIBIT B  In consideration of the promises made by the Company to Employee in the Separation Agreement and Complete Release of Liability to which this Exhibit B is attached, Employee agrees to the following additional post-employment covenants:  1.  Anti-Solicitation of Employees.  During the Severance Pay Period, Employee will not, directly or indirectly, or by action in concert with others, solicit or induce or attempt to solicit or induce, any person who is employed by the Company to leave his or her employment with the Company and/or to perform services of any kind for any other person, firm or corporation.  2. Anti-Solicitation of Customers and Clients.  During the Severance Pay Period, Employee will not, directly or indirectly, either on Employee’s own behalf or on behalf of any other person, firm, or corporation, divert or take away, or call on or solicit or attempt to call on or solicit, any of the Company’s current customers or clients, including those on whom Employee called on or who Employee solicited or with whom Employee became acquainted while engaged as an employee of the Company.  3. Non-Competition.  During the Severance Pay Period, Employee will not accept an employment or consulting relationship (or own or have any financial interest in), directly or indirectly, with any entity engaged in the business of providing services to military, government and commercial customers within Vectrus’ specific lines of service.  4. Covenant Against Disclosure.  Employee will not, at any time, disclose information identified as confidential or which, from the circumstances, in good faith, and good conscience ought to be treated as confidential, relating to the products, services, inventions, discoveries, trade secrets, secret processes, price lists, business plans, or any other information of the business or affairs of the Company or any other person, firm, or corporation, which Employee acquired or developed in connection with or as a result of Employee’s employment with the Company.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}]]